EGOT and breast cancer: The findings showed that AP003469.2 and Z68871.1 considerably increased in BC tissues while LINC01871, AC245297.3, EGOT, TFAP2A-AS1, AL136531.1, SEMA3B-AS1, and AL606834.2 significantly decreased (Figure 14).